U.S. Pharmaceuticals & Biotech Leverage Leaders

Biogen

Market Cap: US$18.1b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Corcept Therapeutics

Market Cap: US$7.8b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Stevanato Group

Market Cap: US$6.4b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

ADMA Biologics

Market Cap: US$4.6b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Revolution Medicines

Market Cap: US$7.3b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

ACADIA Pharmaceuticals

Market Cap: US$2.9b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Vaxcyte

Market Cap: US$4.0b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Qiagen

Market Cap: US$9.1b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Exelixis

Market Cap: US$12.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Catalyst Pharmaceuticals

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

United Therapeutics

Market Cap: US$13.7b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Merus

Market Cap: US$2.8b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Incyte

Market Cap: US$12.1b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Neurocrine Biosciences

Market Cap: US$11.9b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Belite Bio

Market Cap: US$2.2b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.

Bio-Techne

Market Cap: US$7.6b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Xenon Pharmaceuticals

Market Cap: US$2.3b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Apogee Therapeutics

Market Cap: US$2.4b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.

Roivant Sciences

Market Cap: US$7.7b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

Denali Therapeutics

Market Cap: US$2.1b

A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.

Vericel

Market Cap: US$2.1b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Krystal Biotech

Market Cap: US$3.8b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Summit Therapeutics

Market Cap: US$17.1b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Vertex Pharmaceuticals

Market Cap: US$111.5b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Viking Therapeutics

Market Cap: US$3.1b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

West Pharmaceutical Services

Market Cap: US$15.1b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Veracyte

Market Cap: US$2.3b

Operates as a diagnostics company in the United States and internationally.

BioMarin Pharmaceutical

Market Cap: US$11.4b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Natera

Market Cap: US$20.4b

A diagnostics company, provides molecular testing services worldwide.

Protagonist Therapeutics

Market Cap: US$2.8b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Avidity Biosciences

Market Cap: US$3.5b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Moderna

Market Cap: US$9.1b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Crinetics Pharmaceuticals

Market Cap: US$2.9b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Alkermes

Market Cap: US$5.1b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Immunovant

Market Cap: US$2.4b

A clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.

Medpace Holdings

Market Cap: US$8.5b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.